NanoGroup S.A. (WSE:NNG)

Poland flag Poland · Delayed Price · Currency is PLN
2.470
-0.070 (-2.76%)
Apr 28, 2026, 5:00 PM CET
-21.09%
Market Cap 108.28M
Revenue (ttm) -6.90K
Net Income (ttm) -6.93M
Shares Out 42.63M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,672
Average Volume 56,901
Open 2.490
Previous Close 2.540
Day's Range 2.470 - 2.525
52-Week Range 2.250 - 3.620
Beta 0.64
RSI 43.49
Earnings Date Apr 23, 2026

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.

Financial Statements

News

There is no news available yet.